Malcolm Boyce (C Allen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 7

Top Venues

European journal of clinical pharmacology

British journal of clinical pharmacology

Journal of neuroendocrinology

International journal of rheumatic diseases

Hammersmith Medicines Research

Bristol University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hammersmith Medicines Research

United Kingdom

Medical and Managing Director

Education History

Bristol University

United Kingdom

BSC

Publications

Nina Stojcheva, Stacy Gladman, Marianne Soergel, Christof Zitt, Roxana Drake, Tony Lockett, Carine Marchand, Pierre Fustier, Vaia Stavropoulou, Elena Fernandez, Nathana Lopes Pettigiani, Kate Watkins, Adeep Puri, Randall Watson, Philippe Legenne, Michael Stumpp, Malcolm Boyce
Ensovibep, a SARS-CoV-2 antiviral DARPin, is safe and well tolerated in healthy volunteers: results of a first-in-human, ascending single-dose Phase 1 study. British journal of clinical pharmacology (2023)
Duan Chen, Susan J Hagen, Malcolm Boyce, Chun-Mei Zhao
Neuroendocrine mechanism of gastric acid secretion: Historical perspectives and recent developments in physiology and pharmacology. Journal of neuroendocrinology (2023)
Dominic Beale, Jeremy Dennison, Malcolm Boyce, Francesca Mazzo, Naoki Honda, Paul Smith, Mark Bruce
ONO-7684 a novel oral FXIa inhibitor: Safety, tolerability, pharmacokinetics and pharmacodynamics in a first-in-human study. British journal of clinical pharmacology 87 (8) (2021)
Rieke E Alten, Colin Markland, Malcolm Boyce, Kazuki Kawakami, Rafael Muniz, Mark C Genovese
Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis. International journal of rheumatic diseases 23 (11) (2020)
Malcolm Boyce, G Francis, J Martin, M Boyce
Regulatory experience of TOPS: an internet-based system to prevent healthy subjects from over-volunteering for UK clinical trials. European journal of clinical pharmacology 73 (12) (2017)
Malcolm Boyce, Frans van den Berg, Toni Mitchell, Kate Darwin, Steve Warrington
Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity. European journal of clinical pharmacology 73 (7) (2017)
Malcolm Boyce, Frans van den Berg, Toni Mitchell, Kate Darwin, Steve Warrington
Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity. European journal of clinical pharmacology 73 (2) (2016)

Malcolm Boyce.css-eqlu8i{font-size:small;padding-left:4px;} (C Allen)

Publication Activity (10 Years)

Top Topics

Top Venues

Malcolm Boyce (C Allen)